CIP
XLRN

Convergence Investment Partners’s Acceleron Pharma Inc. XLRN Stock Holding History

Convergence Investment Partners’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,764
Closed -$149K – 334
2019
Q3 		$149K Buy
+3,764
New +$149K 0.04% 252
2014
Q2 		– Sell
-23,460
Closed -$809K – 439
2014
Q1 		$809K Buy
+23,460
New +$809K 0.12% 234